Click here to register for access to CanadianHealthcareNetwork.ca
Once Registered, you can access CE Lessons
Here
Questions marked with an asterisk (*) require a response to be eligible.
First Name:
*
Last Name:
*
Email:
*
Do you read the Tech Talk Newsletter?
*
Often
Sometimes
Rarely
Never
If "rarely" or "never" why?
*
Don’t receive it regularly
Don’t know how to receive it
Don’t find it relevant to my workplace
How often do you do Tech Talk CEs?
*
5 or more per year
4 per year
3 per year
2 per year
1 per year
Never
How do you receive the Tech Talk newsletter and CE?
*
I receive a print version directly
I receive a print version from a pharmacist
I go online to access it
Both, I go online and receive a print version
What do you like best about the Tech Talk newsletter
(check all that apply)
Provincial news
Regulatory news
Profiles of technicians
Tech refresher
Other:
What do you like best about the Tech Talk CE?
(check all that apply)
Topic relevance to my workplace
Ease of use
Online accessibility of the lessons
What topics would you like to read about in the Tech Talk newsletter?
What topics would you like to learn about in the Tech Talk CE?
Who sponsors Tech Talk newsletter and CE?
*
Apotex
Cobalt
Pharmascience
Teva
Sandoz
I don't know
What level of influence (or responsibility) do you currently have in pharmaceutical buying decisions in your pharmacy?
*
High
Medium
Low
None
Do you think regulation will give pharmacy technicians more responsibility in pharmaceutical buying decisions?
*
Yes
No
Not sure
Has your awareness of the sponsor of Tech Talk CE and newsletter influenced your purchasing decisions?
*
Yes
No
I am not involved in purchasing decisions
Would you say your level of influence has increased, decreased or remained the same compared to three years ago?
*
Increased
Decreased
Remained the same
Thinking of your pharmacy, what would you say are the most important functions for regulated or licensed pharmacy technicians?
(Check all that apply)
Dispensing prescriptions
Drug distribution/inventory management
Third-party drug plan issues
Gathering drug/medical safety information
Support for expanded services
General follow-up with patients
General follow-up with physicians
Maintenance of patient-care documentation
Specialty compounding
Other:
Want to share this survey with a friend?
Click here